awmsg logo



avanafil (Spedra®)


Reference No. 1261

Publication date:
16/07/2015


Appraisal information

avanafil (Spedra®) 50 mg tablet
avanafil (Spedra®) 100 mg tablet
avanafil (Spedra®) 200 mg tablet


Company: A. Menarini Farmaceutica Internazionale SRL
BNF category: Obstetrics, gynaecology, and urinary-tract disorders
NMG meeting date: 13/05/2015
AWMSG meeting date: 17/06/2015
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 1715
Ministerial ratification: 15/07/2015

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Avanafil (Spedra®) is recommended as an option for use within NHS Wales for the treatment of erectile dysfunction in adult men.
Final Appraisal Recommendation (FAR)
Download
AWMSG Secretariat Appraisal Report (ASAR)
Download
Clinical Expert (CE) Summary
Download